Skip to main content

Table 3 Matters relating to conservative treatment

From: Factors affecting pregnancy outcomes in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasia

 

Total

Pregnancy

Non-pregnancy

P*

Age of pregnancy permission

35.0 ± 4.7

33.9 ± 4.4

36.0 ± 4.8

0.023

Number of D&C (times)

4.98 ± 3.27

4.18 ± 2.34

5.66 ± 3.77

0.049

Endometrial thickness during ovulation (mm)

7.50 ± 2.08

8.56 ± 1.87

6.70 ± 1.87

<0.001

Duration of MPA administration (days)

357.7 ± 285.4

277.5 ± 167.0

431.5 ± 342.5

0.010

Periods of disappearance of lesions (days)

164.0 ± 143.1

136.2 ± 133.8

187.0 ± 147.7

0.042

Periods from the last MPA administration to menstruation or starting date of the pregnancy (days)

 

314.0 ± 392.8

ー

ー

Infertile period after conservative treatment (days)

1146 ± 1024

1206 ± 887

1096 ± 1131

0.116

Follow up (days)

2032 ± 1266

2027 ± 1115

2037 ± 1389

0.592

Recurrence (%)

61 (62.2)

23 (51.1)

38 (71.7)

0.036

Intrauterine adhesion (%)

20/81 (24.7)

5/29 (17.2)

15/52 (28.8)

0.191

  1. Note : Values listed as mean ± standard deviation
  2. *Pregnancy versus Non-pregnancy (Mann–Whitney U test)